Clinical study on serum IGF-Ⅱ levels in type 2 diabetic nephropathy

ZHANG Bei,LI Chengjiang
DOI: https://doi.org/10.3969/j.issn.1006-2785.2007.03.008
2007-01-01
Abstract:Objective To investigate serum IGF-Ⅱ levels in Type 2 Diabetes patients and the relationship between IGF-Ⅱ and other parameters.Methods The fasting serum IGF-Ⅱ levels were measured by ELLSA method in 148 T2DM patients including 95 diabetic patients without nephropathy,53 patients with diabetic nephropathy and 30 healthy individuals(control group) .Blood glucose,24-hour urinary albumin(UAE) ,growth hormone(GH) ,homeostasis model assessment insulin resistance index(HOMA-IRI) and other clinical parameters were also measured in T2DM patients.Results The serum IGF-Ⅱ levels in non-diabetic nephropathy group(76.07±64.00μg/l) was significantly lower than that in control group(102.45±40.73 μg/l,P<0.05) .And no difference was found between diabetic nephropathy group(91.75±74.79 μg/l) and control group,non-diabetic nephropathy group and diabetic nephropathy group.There was no significant relationship between IGF-Ⅱ and GH(P<0.05) ,IGF-Ⅱ and HOMA-IRI.But the UAE had significant positive correlation with IGF-Ⅱ(P<0.05) .Conclusion The serum IGF-Ⅱ levels in non-diabetic nephropathy group is significantly lower than that of the control group,but not for diabetic nephropathy patients.
What problem does this paper attempt to address?